BPG is committed to discovery and dissemination of knowledge
- Number of total visits
-
33022479
- Number of visits today
- 7917
- Number of downloads
-
16211927
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Wang X, He S, Wang K, Wang X, Yan T, Yan T, Wang Z. Fabrication of betamethasone micro- and nanoparticles using supercritical antisolvent technology: In vitro drug release study and Caco-2 cell cytotoxicity evaluation. Eur J Pharm Sci 2023;181:106341. [PMID: 36435356 DOI: 10.1016/j.ejps.2022.106341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Gresele P, Momi S. Novel approaches to antiplatelet therapy. Biochemical Pharmacology 2022;206:115297. [DOI: 10.1016/j.bcp.2022.115297] [Reference Citation Analysis]
|
3 |
Felipe JL, Cassamale TB, Lourenço LD, Carvalho DB, das Neves AR, Duarte RCF, Carvalho MG, Toffoli-Kadri MC, Baroni ACM. Anti-inflammatory, ulcerogenic and platelet activation evaluation of novel 1,4-diaryl-1,2,3-triazole neolignan-celecoxib hybrids. Bioorg Chem 2021;119:105485. [PMID: 34959176 DOI: 10.1016/j.bioorg.2021.105485] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345